SEC Form 3/A · accession 0001262170-16-000003
NEXIEN BIOPHARMA, INC. · NXEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 3/A). It replaces an earlier filing for the same period.
Reporting owner
Ivo Heiden
Officer — CEO and Chairman · Director · 10% Owner
Period of report
Jan 13, 2015
Accepted (ET)
Sep 6, 2016 · 12:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001625288
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 10,000,000 | D |
Table II — derivative securities
No Table II lines on this filing.